Geerts H

General

Full name : Geerts Hugo

First name : Hugo

Mail : Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Zip Code :

City :

Country : USA

Email : Hugo-Geerts@In-Silico-Biosciences.com

Phone :

Fax :

Website :

Directory :

References (9)

Title : Simulations of symptomatic treatments for Alzheimer's disease: computational analysis of pathology and mechanisms of drug action - Roberts_2012_Alzheimers.Res.Ther_4_50
Author(s) : Roberts PD , Spiros A , Geerts H
Ref : Alzheimers Res Ther , 4 :50 , 2012
Abstract :
PubMedSearch : Roberts_2012_Alzheimers.Res.Ther_4_50
PubMedID: 23181523

Title : Beyond in vitro data: a review of in vivo evidence regarding the allosteric potentiating effect of galantamine on nicotinic acetylcholine receptors in Alzheimer's neuropathology - Coyle_2007_J.Alzheimers.Dis_11_491
Author(s) : Coyle JT , Geerts H , Sorra K , Amatniek J
Ref : J Alzheimers Dis , 11 :491 , 2007
Abstract :
PubMedSearch : Coyle_2007_J.Alzheimers.Dis_11_491
PubMedID: 17656829

Title : Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease - Geerts_2006_J.Clin.Pharmacol_46_8S
Author(s) : Geerts H , Grossberg GT
Ref : Journal of Clinical Pharmacology , 46 :8S , 2006
Abstract :
PubMedSearch : Geerts_2006_J.Clin.Pharmacol_46_8S
PubMedID: 16809810

Title : Indicators of neuroprotection with galantamine - Geerts_2005_Brain.Res.Bull_64_519
Author(s) : Geerts H
Ref : Brain Research Bulletin , 64 :519 , 2005
Abstract :
PubMedSearch : Geerts_2005_Brain.Res.Bull_64_519
PubMedID: 15639548

Title : Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits - Geerts_2005_Brain.Res_1033_186
Author(s) : Geerts H , Guillaumat PO , Grantham C , Bode W , Anciaux K , Sachak S
Ref : Brain Research , 1033 :186 , 2005
Abstract :
PubMedSearch : Geerts_2005_Brain.Res_1033_186
PubMedID: 15694923

Title : [Pharmacology of Alzheimer's disease: where do we go from here?] - Sellal_2005_Therapie_60_89
Author(s) : Sellal F , Nieoullon A , Michel G , Michel BF , Lacomblez L , Geerts H , Delini-Stula A , Bentue-Ferrer D , Bordet R , Allain H
Ref : Therapie , 60 :89 , 2005
Abstract :
PubMedSearch : Sellal_2005_Therapie_60_89
PubMedID: 15969312

Title : Nicotinic receptor modulation: advantages for successful Alzheimer's disease therapy - Geerts_2002_J.Neural.Transm.Suppl_62_203
Author(s) : Geerts H , Finkel L , Carr R , Spiros A
Ref : J Neural Transm Suppl , 62 :203 , 2002
Abstract :
PubMedSearch : Geerts_2002_J.Neural.Transm.Suppl_62_203
PubMedID: 12456064

Title : The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease - Grantham_2002_J.Neurol.Sci_203-204_131
Author(s) : Grantham C , Geerts H
Ref : Journal of Neurology Sci , 203-204 :131 , 2002
Abstract :
PubMedSearch : Grantham_2002_J.Neurol.Sci_203-204_131
PubMedID: 12417371

Title : Nicotinic cholinergic modulation: galantamine as a prototype - Woodruff-Pak_2002_CNS.Drug.Rev_8_405
Author(s) : Woodruff-Pak DS , Lander C , Geerts H
Ref : CNS Drug Rev , 8 :405 , 2002
Abstract :
PubMedSearch : Woodruff-Pak_2002_CNS.Drug.Rev_8_405
PubMedID: 12481195